The patent pending OraVital System is evidence-based. Our philosophy is directed by research and science. The basis of the scientific precepts of OraVital evolved from the 15 years of research and successful clinical evidence in the Fresh Breath Clinic operated by Dr. Julian Geller, DDS, and the extensive research of the late Dr. Walter Loesche.
Dr. Walter Loesche is one of the world’s authorities on caries and periodontal disease, and a former Marcus L. Ward Professor of Dentistry in the Department of Biologic Materials Sciences at the University of Michigan School of Dentistry.
“Treatment of Oral Malodor and Periodontal Disease Using an Antibiotic Rinse”
You can read the study here.
The purpose of this study, originally published in the Academy of General Dentistry publication, General Dentistry was to determine the effectiveness of an antibiotic rinse preparation, containing metronidazole and nystatin, in decreasing oral malodor and periodontal disease for individuals whose chief complaint was halitosis.
The OraVital System is a strong proponent of the superior efficacy of interdental devices compared to dental floss for controlling plaque and biofilm. This study is a meta-analysis of the efficacy of the main types of plaque control for preventing periodontitis, including self-administered inter-dental mechanical plaque control.
Download the PDF of this study.
“Using an Antibiotic Rinse System: An Adjunct in the Treatment of Periodontal Disease”
This study published in Oral Health Magazine stated that the structure and behaviour of biofilm is what makes treatment of these periodontal infections difficult. It has been found that the minimal inhibitory concentration dose for antibiotics and antimicrobials for bacteria in biofilm may be 20 to 200 times higher than required for free floating or plankton bacteria. The study examined oral antibiotics as a possible solution for controlling these persistent bacteria. Here are the findings: